Ranbaxy Seeks Nexium Generic API Sources In Face Of Nearby Launch
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories is discussing with at least two companies with U.S. FDA-approved factories to supply it with the active pharmaceutical ingredients it relies on for its generic of AstraZeneca's Nexium (esomeprazole) for treating heartburn.